Factor X Inhibitor Profile, Technical Interpretation
Use
This test provides a technical interpretation of inhibitor to coagulation factor X testing. Coagulation factor inhibitors can arise in patients congenitally deficient in a specific factor in response to replacement therapy, spontaneously, or in response to conditions such as postpartum state, immunologic disorders, certain antibiotics, malignancies, and advanced age. It evaluates the presence or absence of a factor X inhibitor through interpretive comments based on factor activity results.
Special Instructions
This test is only orderable as part of a profile. For more information, refer to test 10INE / Factor X Inhibitor Evaluation, Plasma. An interpretive report will be provided when testing is complete.
Limitations
Occasionally, a potent lupus-like anticoagulant may cause false-positive testing for specific factor inhibitors such as factor VIII or IX. Additionally, if factor activity results are within normal ranges, inhibitor testing may not be indicated or performed.
New York Approved
Methodology
Other
Biomarkers
LOINC Codes
- 69049-5
- 69049-5
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Collect in sodium citrate tube. Plasma should be separated and frozen within 4 hours of collection.
Causes for Rejection
Gross hemolysis, gross lipemia, gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Frozen | 14 days |